1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine

C44H53ClF4N12 — CID 91498712

IUPAC1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine
SMILESCc1nc(N(CCCC2CCN(C)CC2)N(CCCC2CCN(C)CC2)c2ncc(-c3nc4c(C)c(F)ccc4[nH]3)c(C(F)(F)F)n2)ncc1-c1nc2c(C)c(Cl)ccc2[nH]1
InChIInChI=1S/C44H53ClF4N12/c1-26-33(45)10-12-35-37(26)55-40(53-35)31-24-50-42(52-28(31)3)60(18-6-8-29-14-20-58(4)21-15-29)61(19-7-9-30-16-22-59(5)23-17-30)43-51-25-32(39(57-43)44(47,48)49)41-54-36-13-11-34(46)27(2)38(36)56-41/h10-13,24-25,29-30H,6-9,14-23H2,1-5H3,(H,53,55)(H,54,56)
InChIKeyIWJBJTHQDWVREC-UHFFFAOYSA-N
MW861.44 g/mol
LogP9.56
Rot. Bonds13

About 1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine

1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine (PubChem CID 91498712) has the molecular formula C44H53ClF4N12 and a molecular weight of 861.44 g/mol. Its IUPAC name is 1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine.

Molecular Properties

Compound Name1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine
PubChem CID91498712
Molecular FormulaC44H53ClF4N12
Molecular Weight861.44 g/mol
Exact Mass860.41
IUPAC Name1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine
SMILESCc1nc(N(CCCC2CCN(C)CC2)N(CCCC2CCN(C)CC2)c2ncc(-c3nc4c(C)c(F)ccc4[nH]3)c(C(F)(F)F)n2)ncc1-c1nc2c(C)c(Cl)ccc2[nH]1
InChIInChI=1S/C44H53ClF4N12/c1-26-33(45)10-12-35-37(26)55-40(53-35)31-24-50-42(52-28(31)3)60(18-6-8-29-14-20-58(4)21-15-29)61(19-7-9-30-16-22-59(5)23-17-30)43-51-25-32(39(57-43)44(47,48)49)41-54-36-13-11-34(46)27(2)38(36)56-41/h10-13,24-25,29-30H,6-9,14-23H2,1-5H3,(H,53,55)(H,54,56)
InChIKeyIWJBJTHQDWVREC-UHFFFAOYSA-N
XLogP9.56
TPSA121.88 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds13
Heavy Atoms61
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500861.44
LogP ≤ 59.56
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine?
The IUPAC name of 1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine (CID 91498712) is 1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine.
What is the SMILES notation for 1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine?
The canonical SMILES for 1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine is Cc1nc(N(CCCC2CCN(C)CC2)N(CCCC2CCN(C)CC2)c2ncc(-c3nc4c(C)c(F)ccc4[nH]3)c(C(F)(F)F)n2)ncc1-c1nc2c(C)c(Cl)ccc2[nH]1.
What is the InChIKey of 1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine?
The InChIKey is IWJBJTHQDWVREC-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H53ClF4N12/c1-26-33(45)10-12-35-37(26)55-40(53-35)31-24-50-42(52-28(31)3)60(18-6-8-29-14-20-58(4)21-15-29)61(19-7-9-30-16-22-59(5)23-17-30)43-51-25-32(39(57-43)44(47,48)49)41-54-36-13-11-34(46)27(2)38(36)56-41/h10-13,24-25,29-30H,6-9,14-23H2,1-5H3,(H,53,55)(H,54,56).
What are the key properties of 1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine?
1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine has a molecular weight of 861.44 g/mol, XLogP of 9.56, 13 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[5-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-4-methylpyrimidin-2-yl]-2-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-4-(trifluoromethyl)pyrimidin-2-yl]-1,2-bis[3-(1-methylpiperidin-4-yl)propyl]hydrazine is sourced from PubChem (CID 91498712), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).